Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03544957
Other study ID # 2018-02Obs-CHRMT
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 1, 2018
Est. completion date April 1, 2019

Study information

Verified date April 2018
Source Centre Hospitalier Régional Metz-Thionville
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study tried to describe diagnostic properties of TRST completed by an emergency doctor, for screening process for fragility of elderly subjects admitted at the accident and emergency department.


Description:

A constant increase of emergencies admission of elderly subjects is registered. The current problem is the identification and early screening of these patients upon admission at the accident and emergency department for early tracking in geriatric network. This early assessment could allow a shorter waiting time, a better orientation of patients and a decrease in the number of re-hospitalization.

There are many screening process for fragility tests but there seem to be nonspecifically. The advantage of TRST is its simplicity and speed of filling.

In 2015, Duc et al. have found that TRST may be a screening instrument for elderly subject and is going to require geriatric mobile team (GMT) for evaluation. Unfortunately, the threshold may be too sensitive and GMT solicitation is too high.


Recruitment information / eligibility

Status Completed
Enrollment 199
Est. completion date April 1, 2019
Est. primary completion date January 1, 2019
Accepts healthy volunteers No
Gender All
Age group 75 Years and older
Eligibility Inclusion Criteria:

- Patients who are more than 75 years old

- Admitted to the emergency department for medical or surgical reason

- Admitted from Monday to Friday (8h30 AM- 6h PM)

Exclusion Criteria:

- Patient with specific care (vital emergency, urgent surgery)

- Patient or his support person opposing the use of data

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France CHR Metz Thionville Metz Moselle

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Régional Metz-Thionville

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary TRST-U Triage Risk Screening Tool completed by an emergency doctor Day 1
Secondary TRST-G Triage Risk Screening Tool completed by a geriatrician Day 1
Secondary SEGA instrument Evaluation of TRST versus SEGA instrument (gold standard) Day 1